Cargando…

Toll-Like Receptor Signaling in Liver Diseases

Detalles Bibliográficos
Autores principales:	Szabo, Gyongyi, Billiar, Timothy R., Machida, Keigo, Crispe, Ian Nicholas, Seki, Ekihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123973/ https://www.ncbi.nlm.nih.gov/pubmed/21789039 http://dx.doi.org/10.1155/2010/971270

Ejemplares similares

Toll-Like Receptor Signaling and Liver Fibrosis
por: Aoyama, Tomonori, et al.
Publicado: (2010)

Toll-Like Receptors in Liver Fibrosis: Cellular Crosstalk and Mechanisms
por: Yang, Ling, et al.
Publicado: (2012)

Toll-Like Receptors in the Pathogenesis of Alcoholic Liver Disease
por: Petrasek, Jan, et al.
Publicado: (2010)

Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease
por: Miura, Kouichi, et al.
Publicado: (2010)

Acrolein, a New Villain in the Development of Alcoholic Liver Disease
por: Seki, Ekihiro
Publicado: (2016)

Nuclear Receptors: Opening Up New Avenues of Pediatric Fatty Liver Research
por: Pandyarajan, Vijay, et al.
Publicado: (2018)

Toll-Like Receptors in Hepatic Ischemia/Reperfusion and Transplantation
por: Evankovich, John, et al.
Publicado: (2010)

FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
por: Kim, Jieun, et al.
Publicado: (2023)

Intestinal Lipolysis Mitigates Nonalcoholic Fatty Liver Disease: New Roles for Carboxylesterase 2c in the Intestine
por: Pimienta, Michael, et al.
Publicado: (2019)

Toll-Like Receptors and Myocardial Ischemia/Reperfusion, Inflammation, and Injury
por: Kaczorowski, David J, et al.
Publicado: (2009)

Basic and Clinical Advances in Chronic Liver Inflammation
por: Enomoto, Hirayuki, et al.
Publicado: (2016)

Kupffer Cell TLR2/3 Signaling: A Pathway for EGCG Amelioration of Ethanol-Induced Hepatic Injury
por: Czech, Torrey Y., et al.
Publicado: (2019)

Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
por: Lepper, Philipp M., et al.
Publicado: (2010)

PPARs and Liver Disease
por: Kondo, Yasuteru, et al.
Publicado: (2013)

A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1
por: Czech, Torrey Y., et al.
Publicado: (2018)

Toll-Like Receptor 3 in Liver Diseases
por: Yin, Shi, et al.
Publicado: (2010)

Toll-like receptors in pathophysiology of liver diseases
por: Kiziltas, Safak
Publicado: (2016)

TAK1-dependent autophagy: A suppressor of fatty liver disease and hepatic oncogenesis
por: Seki, Ekihiro
Publicado: (2014)

Endogenous Histones Function as Alarmins in Sterile Inflammatory Liver Injury Through Toll-like Receptor 9 in Mice
por: Huang, Hai, et al.
Publicado: (2011)

The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation
por: Kircheis, Ralf, et al.
Publicado: (2023)

Tumor Suppressor Down-Regulation Promotes Hepatocyte Proliferation: A New GANKster on the Block
por: Pimienta, Michael, et al.
Publicado: (2018)

Crossing the Rubicon: Adipose Tissue Autophagy Breaks Out NAFLD
por: Kim, Jieun, et al.
Publicado: (2021)

Accelerated Calvarial Healing in Mice Lacking Toll-Like Receptor 4
por: Wang, Dan, et al.
Publicado: (2012)

HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling
por: Tsung, Allan, et al.
Publicado: (2007)

Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis
por: Guo, Jinsheng, et al.
Publicado: (2010)

Toll-like receptor 2: therapeutic target for gastric carcinogenesis
por: McCormack, William, et al.
Publicado: (2012)

Toll-like receptor 4 in COVID-19: friend or foe?
por: Mukherjee, Suprabhat
Publicado: (2022)

Toll-like receptor downstream signaling
por: Kawai, Taro, et al.
Publicado: (2005)

Toll-Like Receptor Signaling Pathways
por: Kawasaki, Takumi, et al.
Publicado: (2014)

Alcoholic liver disease: A current molecular and clinical perspective()
por: Ohashi, Koichiro, et al.
Publicado: (2018)

Toll-like receptor 5-mediated signaling enhances liver regeneration in mice
por: Zhang, Wen, et al.
Publicado: (2021)

Mycobacterial signaling through toll-like receptors
por: Basu, Joyoti, et al.
Publicado: (2012)

Toll-like receptor signaling and stages of addiction
por: Crews, Fulton T., et al.
Publicado: (2017)

Patents for Toll-like receptor ligands as radiation countermeasures for acute radiation syndrome
por: Singh, Vijay K, et al.
Publicado: (2015)

Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?
por: Jeong, Soung Won
Publicado: (2020)

Hyaluronan in liver fibrosis: basic mechanisms, clinical implications, and therapeutic targets
por: Kim, Jieun, et al.
Publicado: (2023)

A new “sweet” ligand for Toll-like receptor 4
por: Deierborg, Tomas, et al.
Publicado: (2015)

Introducing Hepatology Communications
por: Szabo, Gyongyi
Publicado: (2017)

Hepatology Communications Achieves First Impact Factor and MEDLINE Indexing
por: Szabo, Gyongyi
Publicado: (2021)

Toll-like Receptors and Celiac Disease
por: Talipova, Diana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vd1ndce34c5ivicog7q9ng5aaq